NeuroAiD(TM)II holds promise as a safe add-on therapy to sta

/PRNewswire/ -- Moleac is pleased to announce the release of the ATHENE study results, published in the Journal of the American Medical Director Association...

Related Keywords

China , United States , Jamda , Xizang , Singapore , National University Of Singapore , Singapore General , Chinese , American , Prnewswire Moleac , Christopher Chen , National University Health System , Journal Of The American Medical Directors Association , Cognition Centre , National Neuroscience Institute , Yong Loo Lin School Of Medicine , Department Of Pharmacology , American Medical Director Association , Memory Ageing , Memory Aging , Associate Professor , Yong Loo Lin School , National University , Randomized Double Blind Delayed Start , American Medical Directors Association , Amyloid Precursor Protein , Cerebrovasc Dis , Eurj Neurol , Moleac ,